Most autoimmune diseases are easy to diagnose but hard to treat. A paper published today in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune disease.
Apr 7, 2022
0
507
Mutations in a vital class of regulatory molecules are an underappreciated cause of cancer because they impair the function of "G" proteins, a versatile and vast family of signaling switches that underlie innumerable biological ...
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, ...
Jul 8, 2019
0
3
Attention deficit hyperactivity disorder (ADHD) affects about 7% of children, with a two out of three chance of persisting into adulthood. This neurodevelopmental disorder is characterized by concentration difficulties, increased ...
Jun 29, 2021
0
5
A University of California, Riverside, research team has come up with a new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs.
May 17, 2019
0
208
A study by a team of Victoria University of Wellington scientists spotlights the role of gene networks in how people respond to one of the world's most prescribed medications.
Oct 4, 2019
1
129
Drug companies are working to develop a pure, more powerful version of the nation's second most-abused medicine, which has addiction experts worried that it could spur a new wave of abuse.
Dec 26, 2011
7
0
Incentives intended to stimulate the development of more treatments for rare diseases are being exploited to boost the profits of pharmaceutical companies, new research led by Bangor University shows.
Oct 21, 2016
3
94
Over 25,000 Canadians have died from opioid overdose since 2016—with 6,306 people dying in 2020 alone.
Mar 14, 2022
0
2
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
